Jun 20, 2017 9:00 AM
Congratulations to Dr. Sabari Radhakrishnan who was awarded a two year American Association for Cancer Research-Pfizer Immuno-Oncology Fellowship. This fellowship was established in 1996 and provides funding to promising young investigators who have strong potential to become productive and successful independent cancer research scientists. Dr. Radhakrishnan's research focuses on chimeric antigen receptor (CAR) T cell therapy for multiple myeloma. He has generated multiple CAR T cells targeting a multiple myeloma surface antigen and is testing the efficacy of his CAR T cells in a mouse multiple myeloma model system.